Back to calendar
Lineage Cell Therapeutics, Inc. (LCTX) Earnings
LCTX reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.03
Actual EPS: $-0.03
EPS surprise: -5.88%
Company overview
Market Cap$278.2M
PriceUSD 1.10
EPS (TTM)-0.18
52-week high2.09
52-week low1.00
SectorHealth Technology
IndustryBiotechnology
Employees77